Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.

ABSTRACT: ALK, ROS1 and RET gene fusions are important predictive biomarkers for tyrosine kinase inhibitors in lung cancer. Currently, the gold standard method for gene fusion detection is Fluorescence In Situ Hybridization (FISH) and while highly sensitive and specific, it is also labour intensive, subjective in analysis, and unable to screen a large numbers of gene fusions. Recent developments in high-throughput transcriptome-based methods may provide a suitable alternative to FISH as they are compatible with multiplexing and diagnostic workflows. However, the concordance between these different methods compared with FISH has not been evaluated. In this study we compared the results from three transcriptome-based platforms (Nanostring Elements, Agena LungFusion panel and ThermoFisher NGS fusion pa

SUBMITTER: Rogers TM 

PROVIDER: S-EPMC5299839 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature